Does ARGATROBAN Cause Off label use? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Off label use have been filed in association with ARGATROBAN (Argatroban). This represents 8.1% of all adverse event reports for ARGATROBAN.
55
Reports of Off label use with ARGATROBAN
8.1%
of all ARGATROBAN reports
10
Deaths
21
Hospitalizations
How Dangerous Is Off label use From ARGATROBAN?
Of the 55 reports, 10 (18.2%) resulted in death, 21 (38.2%) required hospitalization, and 12 (21.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARGATROBAN. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does ARGATROBAN Cause?
Drug ineffective (109)
Heparin-induced thrombocytopenia (91)
Haemorrhage (45)
Cerebral infarction (35)
Disseminated intravascular coagulation (35)
Pulmonary embolism (30)
Deep vein thrombosis (29)
Thrombocytopenia (29)
Thrombosis (25)
Cerebral haemorrhage (22)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ARGATROBAN Alternatives Have Lower Off label use Risk?
ARGATROBAN vs ARGININE
ARGATROBAN vs ARGININE\LYSINE
ARGATROBAN vs ARIMIDEX
ARGATROBAN vs ARIPIPRAZOLE
ARGATROBAN vs ARIPIPRAZOLE LAUROXIL